Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.680
-0.070 (-4.00%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $214.47 million as of April 25, 2025. Its market cap has decreased by -69.88% in one year.
Market Cap
214.47M
Enterprise Value
66.10M
1-Year Change
-69.88%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $214.47M, a decrease of -86.82%. That is a compound annual growth rate of -55.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 223.41M | -40.04% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.40B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |